Neda A. Moatamed

1.9k total citations
79 papers, 1.3k citations indexed

About

Neda A. Moatamed is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Neda A. Moatamed has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 21 papers in Cancer Research and 20 papers in Surgery. Recurrent topics in Neda A. Moatamed's work include Breast Cancer Treatment Studies (11 papers), Salivary Gland Tumors Diagnosis and Treatment (10 papers) and Breast Lesions and Carcinomas (8 papers). Neda A. Moatamed is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Salivary Gland Tumors Diagnosis and Treatment (10 papers) and Breast Lesions and Carcinomas (8 papers). Neda A. Moatamed collaborates with scholars based in United States, United Kingdom and Germany. Neda A. Moatamed's co-authors include Sophia K. Apple, Peter Shintaku, Sanaz Memarzadeh, Jiaoti Huang, Bruce A. Hirayama, Hermann Koepsell, Ernest M. Wright, Jorge R. Barrio, Claudio Scafoglio and Jie Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Neda A. Moatamed

74 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Neda A. Moatamed 609 359 321 313 194 79 1.3k
Ewa Chmielik 711 1.2× 563 1.6× 420 1.3× 323 1.0× 467 2.4× 77 1.6k
Christian Ensinger 675 1.1× 707 2.0× 310 1.0× 315 1.0× 254 1.3× 53 1.9k
Diane Kowalski 767 1.3× 628 1.7× 559 1.7× 271 0.9× 129 0.7× 45 2.0k
Itzhak Avital 590 1.0× 486 1.4× 466 1.5× 453 1.4× 66 0.3× 42 1.5k
Elaine T. Lam 677 1.1× 621 1.7× 255 0.8× 528 1.7× 240 1.2× 119 1.8k
Ahwon Lee 415 0.7× 500 1.4× 319 1.0× 440 1.4× 83 0.4× 140 1.8k
Roberta Fasani 326 0.5× 577 1.6× 190 0.6× 206 0.7× 72 0.4× 53 1.4k
Samuel W. Beenken 880 1.4× 344 1.0× 545 1.7× 360 1.2× 198 1.0× 37 1.7k
Pascale Maillé 305 0.5× 644 1.8× 420 1.3× 322 1.0× 76 0.4× 39 1.6k
Selim Nasser 604 1.0× 471 1.3× 470 1.5× 144 0.5× 95 0.5× 44 1.4k

Countries citing papers authored by Neda A. Moatamed

Since Specialization
Citations

This map shows the geographic impact of Neda A. Moatamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neda A. Moatamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neda A. Moatamed more than expected).

Fields of papers citing papers by Neda A. Moatamed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neda A. Moatamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neda A. Moatamed. The network helps show where Neda A. Moatamed may publish in the future.

Co-authorship network of co-authors of Neda A. Moatamed

This figure shows the co-authorship network connecting the top 25 collaborators of Neda A. Moatamed. A scholar is included among the top collaborators of Neda A. Moatamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neda A. Moatamed. Neda A. Moatamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Unterrainer, Lena M., Sanaz Memarzadeh, Neda A. Moatamed, et al.. (2024). [68Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor. Journal of Nuclear Medicine. 65(5). 820–821. 3 indexed citations
2.
Shin, Daniel Sanghoon, Saroj K. Basak, Mysore S. Veena, et al.. (2024). Enhanced CTLA‐4 blockade anti‐tumor immunity with APG‐157 combination in a murine head and neck cancer. Cancer Medicine. 13(9). e7212–e7212. 1 indexed citations
3.
Chan, Ann M., Vei Mah, Justin M. Balko, et al.. (2024). EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancers. 16(8). 1481–1481. 3 indexed citations
4.
Chen, Heather, Wei Hao, Jonas J. Heymann, et al.. (2024). Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023. Journal of the American Society of Cytopathology. 13(3). 194–204. 4 indexed citations
5.
6.
Li, Yan-Ruide, Yichen Zhu, Adam B. Kramer, et al.. (2023). Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design. iScience. 26(10). 107952–107952. 14 indexed citations
7.
Liou, Sofia, Sanaz Memarzadeh, Sarah Dry, Rondell P. Graham, & Neda A. Moatamed. (2021). A rare case of vulvar extraskeletal myxoid chondrosarcoma: mimics and diagnostic clues. Autopsy and Case Reports. 11. e2021322–e2021322. 1 indexed citations
8.
Phan, Nhan Lu-Chinh, Jenny J. Hong, David Elashoff, et al.. (2019). A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids. Communications Biology. 2(1). 78–78. 190 indexed citations
9.
Yang, Sung‐Eun, et al.. (2018). Comparison of Cytopathologist-Performed Ultrasound-Guided Fine-Needle Aspiration With Cytopathologist-Performed Palpation-Guided Fine-Needle Aspiration: A Single Institutional Experience. Archives of Pathology & Laboratory Medicine. 142(10). 1260–1267. 34 indexed citations
10.
11.
Shintaku, Peter, et al.. (2017). Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas. Diagnostic Pathology. 12(1). 45–45. 99 indexed citations
12.
Woo, Jennifer S., Sophia K. Apple, Peggy Sullivan, et al.. (2016). Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience. Diagnostic Pathology. 11(1). 102–102. 18 indexed citations
13.
Engelberg, Jesse A., Hanna Retallack, Ronald Balassanian, et al.. (2015). “Score the Core” Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring. Human Pathology. 46(11). 1694–1704. 11 indexed citations
14.
Moatamed, Neda A., et al.. (2015). Cytokeratin 7 negative invasive breast carcinoma: clinicopathological and immunohistochemical analysis of 14 cases with clinical follow-up. Journal of Clinical Pathology. 68(6). 484–487. 7 indexed citations
15.
16.
Moatamed, Neda A., Gouri J. Nanjangud, Alarice Lowe, et al.. (2011). Effect of Ischemic Time, Fixation Time, and Fixative Type on HER2/neu Immunohistochemical and Fluorescence In Situ Hybridization Results in Breast Cancer. American Journal of Clinical Pathology. 136(5). 754–761. 57 indexed citations
17.
Lu, David, et al.. (2011). Genital rhabdomyoma of the urethra in an infant girl. Human Pathology. 43(4). 597–600. 6 indexed citations
18.
Apple, Sophia K., et al.. (2010). Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma. The Breast. 19(5). 360–364. 3 indexed citations
19.
Apple, Sophia K., Alarice Lowe, P. Nagesh Rao, I. Peter Shintaku, & Neda A. Moatamed. (2009). Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Modern Pathology. 22(9). 1151–1159. 33 indexed citations
20.
Ohsie, Steven J., Neda A. Moatamed, Helena R. Chang, & Sophia K. Apple. (2009). Heterotopic breast tissue versus occult metastatic carcinoma in lymph node, a diagnostic dilemma. Annals of Diagnostic Pathology. 14(4). 260–263.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ewa Chmielik Breakdown of academic impact, for papers by Christian Ensinger Breakdown of academic impact, for papers by Diane Kowalski Breakdown of academic impact, for papers by Itzhak Avital Breakdown of academic impact, for papers by Elaine T. Lam Breakdown of academic impact, for papers by Ahwon Lee Breakdown of academic impact, for papers by Roberta Fasani Breakdown of academic impact, for papers by Samuel W. Beenken Breakdown of academic impact, for papers by Pascale Maillé Breakdown of academic impact, for papers by Selim Nasser
Rankless by CCL
2026